[SCHEDULE 13G/A] Tango Therapeutics, Inc. SEC Filing
Farallon-affiliated funds and related individuals filed an amended Schedule 13G reporting material passive holdings of Tango Therapeutics common stock. Farallon Partners, L.L.C. is shown as beneficial owner of 8,798,334 shares (8.1%) and the Farallon Individual Reporting Persons are shown with a collective 9,157,000 shares (8.4%). Several underlying Farallon funds report individual holdings, including Farallon Capital Offshore Investors II with 3,754,671 shares (3.5%) and Farallon Capital Institutional Partners with 2,023,027 shares (1.9%).
The filing states the shares are held directly by the named funds and that the general partner entities and listed individuals could be deemed beneficial owners while disavowing beneficial ownership of those shares. The Schedule is a passive disclosure of ownership and includes a certification that the securities were not acquired to effect a change of control.
- Material institutional ownership disclosed: Farallon entities report substantial positions, including 8.1% (Farallon Partners) and 8.4% (aggregate individuals).
- Passive disclosure and certification: The filing is a Schedule 13G/A and includes a certification that the securities were not acquired to effect a change of control.
- No sole voting or dispositive power reported for any reporting person; all reported power is shared (sole power rows show 0).
- Group status ambiguous: the Reporting Persons state they "neither disclaim nor affirm" the existence of a group, leaving potential coordination unclear.
Insights
TL;DR Farallon entities report an >8% stake in TNGX, a material institutional holding but disclosed as passive.
This Schedule 13G/A shows concentrated institutional exposure by Farallon-related funds and named principals to Tango Therapeutics common stock. Key figures are 8.1% (Farallon Partners, L.L.C.) and 8.4% (aggregate reported by the Individual Reporting Persons). The positions are reported as shared voting and dispositive power with no sole voting or sole dispositive power indicated for any reporting person. The filing also disclaims affirmative statements about a group while acknowledging potential deemed beneficial ownership through governance roles. For investors, this is material ownership information but presented as passive.
TL;DR Material institutional ownership disclosed with disclaimers about group status and beneficial ownership—governance implications possible but not asserted.
The filing identifies multiple Farallon funds and affiliated entities as holders of Tango common stock, and names 17 individual reporting persons tied to the Farallon General Partner. The document explicitly states that the General Partner and the named individuals "may be deemed" beneficial owners while simultaneously disclaiming beneficial ownership of the reported shares. The filers also note the holdings were not acquired to change control. The combination of concentrated holdings and the group-disclaimer language is a governance item investors may track, though the filing itself presents the position as passive.